iCMR for Ischemic VT Ablation
Ventricular Tachycardia
Clinical DevelopmentActive
Key Facts
Indication
Ventricular Tachycardia
Phase
Clinical Development
Status
Active
Company
About Imricor Medical Systems
Imricor Medical Systems is a commercial-stage medical device company leading the development of interventional cardiac magnetic resonance (iCMR) technology for the treatment of cardiac arrhythmias. Its proprietary platform includes the only FDA-cleared iCMR ablation and diagnostic catheters, a compatible electrophysiology recorder/stimulator, and the NorthStar 3D mapping system, designed to work inside an active MRI. The company aims to transform cardiac ablation by offering real-time, radiation-free visualization of soft tissue and direct visualization of lesion formation. Recent FDA clearances for key system components position Imricor to drive adoption of this next-generation procedural approach.
View full company profileTherapeutic Areas
Other Ventricular Tachycardia Drugs
| Drug | Company | Phase |
|---|---|---|
| SereneRF for Cardiac Arrhythmias | Thermedical | Pre-clinical / Early Clinical |
| Digital Twin for VT Ablation | inHEART | Commercial |